Oncobox

Oncobox is developed to choose drug therapy for difficult and late-stage cancer cases. The platform analyzes the molecular characteristics of a patient's tumor and calculates an individual efficacy rating for over 160 cancer drugs. Oncobox technology is protected by international patents, and its effectiveness has been proven in prospective and retrospective clinical studies. Learn more in the brochure. The patient underwent 6 surgeries, and after last recurrence the tumor was declared inoperable. Chemotherapy and hormone therapy attempts for 2 years were ineffective with further tumor progression being noted. Based on the integral Oncobox Dx results, a tyrosine kinase inhibitor (Sorafenib) was prescribed. There was a partial response to treatment with great tumor size reduction, but the treatment was canceled due to the side effects.